2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow PAH: new trials by email Literature Review of PAH trials Research Report on PAH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CXA-10 Study in Subjects With Pulmonary Arterial Hypertension CXA-10 - PAH | Phase 2 | Terminated | Complexa, Inc. | 33 | 2019-08-09 | 2020-08-26 |
| PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH) 75mg CXA-10, 150mg CXA-10, Placebo - PAH | Phase 2 | Terminated | Complexa, Inc. | 69 | 2018-08-01 | 2020-08-10 |
Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Familial Primary Pulmonary Hypertension (2) · Hypertension (2) · Hypertension, Pulmonary (2) · Lung Diseases (2) · Pulmonary Arterial Hypertension (2) · Vascular Diseases (2)
Respiratory Tract Diseases (2) · Skin and Connective Tissue Diseases (2)
CXA-10 (2)
Complexa, Inc. (2)
United Kingdom (2) · United States (2)
Theo Danoff, MD (2)